Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9848855rdf:typepubmed:Citationlld:pubmed
pubmed-article:9848855lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0038525lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0678812lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0265110lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0023866lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C1552617lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C0282443lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:9848855lifeskim:mentionsumls-concept:C2350691lld:lifeskim
pubmed-article:9848855pubmed:issue6lld:pubmed
pubmed-article:9848855pubmed:dateCreated1999-3-12lld:pubmed
pubmed-article:9848855pubmed:abstractTextIncreasing evidence implicates endothelin (ET)-1 in the pathophysiological development of cerebral vasospasm. This study examined the ability of TBC 11251 (TBC), a new ETA receptor antagonist, to prevent vasospasm in a rabbit model of subarachnoid hemorrhage (SAH).lld:pubmed
pubmed-article:9848855pubmed:languageenglld:pubmed
pubmed-article:9848855pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:citationSubsetIMlld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9848855pubmed:statusMEDLINElld:pubmed
pubmed-article:9848855pubmed:monthDeclld:pubmed
pubmed-article:9848855pubmed:issn0148-396Xlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:LeeK SKSlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:WestKKlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:KassellN FNFlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:HelmG AGAlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:ArthurA SASlld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:WaneboJ EJElld:pubmed
pubmed-article:9848855pubmed:authorpubmed-author:LouisH GHGlld:pubmed
pubmed-article:9848855pubmed:issnTypePrintlld:pubmed
pubmed-article:9848855pubmed:volume43lld:pubmed
pubmed-article:9848855pubmed:ownerNLMlld:pubmed
pubmed-article:9848855pubmed:authorsCompleteYlld:pubmed
pubmed-article:9848855pubmed:pagination1409-17; discussion 1417-8lld:pubmed
pubmed-article:9848855pubmed:dateRevised2008-6-5lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:meshHeadingpubmed-meshheading:9848855-...lld:pubmed
pubmed-article:9848855pubmed:year1998lld:pubmed
pubmed-article:9848855pubmed:articleTitleSystemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.lld:pubmed
pubmed-article:9848855pubmed:affiliationDepartment of Neurosurgery, National Naval Medical Center, Bethesda, Maryland, USA.lld:pubmed
pubmed-article:9848855pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9848855pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9848855pubmed:publicationTypeReviewlld:pubmed
pubmed-article:9848855pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9848855lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9848855lld:pubmed